Identifying shared genetic architecture between rheumatoid arthritis and other conditions: a phenome-wide association study with genetic risk scores

[1]  S. Lei,et al.  Systematic Evaluation of Rheumatoid Arthritis Risk by Integrating Lifestyle Factors and Genetic Risk Scores , 2022, Frontiers in Immunology.

[2]  Theodore G. Drivas,et al.  Large-scale genomic analyses reveal insights into pleiotropy across circulatory system diseases and nervous system disorders , 2022, Nature Communications.

[3]  T. Wang,et al.  The Mass General Brigham Biobank Portal: an i2b2-based data repository linking disparate and high-dimensional patient data to support multimodal analytics , 2021, J. Am. Medical Informatics Assoc..

[4]  Y. Okada,et al.  Dynamic landscape of immune cell-specific gene regulation in immune-mediated diseases , 2021, Cell.

[5]  B. Wieseler,et al.  Comparative effectiveness of biological medicines in rheumatoid arthritis: systematic review and network meta-analysis including aggregate results from reanalysed individual patient data , 2020, BMJ.

[6]  John P. Rice,et al.  A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank , 2020, Nature Communications.

[7]  N. Cox,et al.  Pleiotropy in the Genetic Predisposition to Rheumatoid Arthritis: A Phenome‐Wide Association Study and Inverse Variance–Weighted Meta‐Analysis , 2020, Arthritis & rheumatology.

[8]  Lisa Bastarache,et al.  Mapping ICD-10 and ICD-10-CM Codes to Phecodes: Workflow Development and Initial Evaluation , 2019, JMIR Medical Informatics.

[9]  F. Ibrahim,et al.  A systematic review of guidelines for managing rheumatoid arthritis , 2019, BMC Rheumatology.

[10]  M. Feldman,et al.  Analysis of polygenic risk score usage and performance in diverse human populations , 2019, Nature Communications.

[11]  I. Deary,et al.  A phenome-wide association and Mendelian Randomisation study of polygenic risk for depression in UK Biobank , 2019, Nature Communications.

[12]  J. Sparks.  Rheumatoid Arthritis , 2019, Annals of Internal Medicine.

[13]  P. Donnelly,et al.  The UK Biobank resource with deep phenotyping and genomic data , 2018, Nature.

[14]  Tianxi Cai,et al.  Association of Interleukin 6 Receptor Variant With Cardiovascular Disease Effects of Interleukin 6 Receptor Blocking Therapy: A Phenome-Wide Association Study , 2018, JAMA cardiology.

[15]  Stephanie E. Moser,et al.  Association of Polygenic Risk Scores for Multiple Cancers in a Phenome-wide Study: Results from The Michigan Genomics Initiative , 2017, bioRxiv.

[16]  Hailiang Huang,et al.  Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.

[17]  I. McInnes,et al.  Rheumatoid arthritis , 2016, The Lancet.

[18]  Nicole A. Restrepo,et al.  Shared Genetic Etiology of Autoimmune Diseases in Patients from a Biorepository Linked to De-identified Electronic Health Records , 2016, Front. Genet..

[19]  J. C. Cooke Bailey,et al.  Genetic Risk Scores , 2016, Current protocols in human genetics.

[20]  P. Visscher,et al.  Genetic pleiotropy in complex traits and diseases: implications for genomic medicine , 2016, Genome Medicine.

[21]  Nich Wattanasin,et al.  The Biobank Portal for Partners Personalized Medicine: A Query Tool for Working with Consented Biobank Samples, Genotypes, and Phenotypes Using i2b2 , 2016, Journal of personalized medicine.

[22]  Jane Worthington,et al.  The genetics of rheumatoid arthritis: risk and protection in different stages of the evolution of RA. , 2016, Rheumatology.

[23]  E. Karlson,et al.  Building the Partners HealthCare Biobank at Partners Personalized Medicine: Informed Consent, Return of Research Results, Recruitment Lessons and Operational Considerations , 2016, Journal of personalized medicine.

[24]  R. Toes,et al.  Coeliac disease and rheumatoid arthritis: similar mechanisms, different antigens , 2015, Nature Reviews Rheumatology.

[25]  P. Elliott,et al.  UK Biobank: An Open Access Resource for Identifying the Causes of a Wide Range of Complex Diseases of Middle and Old Age , 2015, PLoS medicine.

[26]  Manolis Kellis,et al.  Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers , 2015, Nature Genetics.

[27]  Xingbin Wang,et al.  Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients , 2015, Immunogenetics.

[28]  D. Kastner,et al.  Genetics, genomics, and their relevance to pathology and therapy. , 2014, Best practice & research. Clinical rheumatology.

[29]  Jun S. Liu,et al.  Genetics of rheumatoid arthritis contributes to biology and drug discovery , 2013 .

[30]  L. Rodrigo,et al.  Celiac Disease and Autoimmune-Associated Conditions , 2013, BioMed research international.

[31]  Buhm Han,et al.  Imputing Amino Acid Polymorphisms in Human Leukocyte Antigens , 2013, PloS one.

[32]  Alexander T. Dilthey,et al.  Multi-Population Classical HLA Type Imputation , 2013, PLoS Comput. Biol..

[33]  G. Wells,et al.  Celiac disease arthropathy and autoimmunity study , 2013, Journal of gastroenterology and hepatology.

[34]  K. Siminovitch,et al.  Meta-analysis of genetic polymorphisms in granulomatosis with polyangiitis (Wegener's) reveals shared susceptibility loci with rheumatoid arthritis. , 2012, Arthritis and rheumatism.

[35]  Robert M. Plenge,et al.  Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis , 2011, Nature Genetics.

[36]  Y. Kochi,et al.  Insight from genome‐wide association studies in rheumatoid arthritis and multiple sclerosis , 2011, FEBS letters.

[37]  Ming-Huei Chen,et al.  A comparison of strategies for analyzing dichotomous outcomes in genome‐wide association studies with general pedigrees , 2011, Genetic epidemiology.

[38]  A. Valdés,et al.  Genetics of the HLA Region in the Prediction of Type 1 Diabetes , 2011, Current diabetes reports.

[39]  L. Sollid,et al.  Integration of genetic and immunological insights into a model of celiac disease pathogenesis. , 2011, Annual review of immunology.

[40]  K. Liao,et al.  A specific association exists between type 1 diabetes and anti-CCP positive rheumatoid arthritis , 2011 .

[41]  J. van Bergen,et al.  Celiac disease: how complicated can it get? , 2010, Immunogenetics.

[42]  N. Breslow,et al.  The association between the PTPN22 1858C>T variant and type 1 diabetes depends on HLA risk and GAD65 autoantibodies , 2010, Genes and Immunity.

[43]  D. Sobel,et al.  Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus , 2010, Acta Diabetologica.

[44]  Atul J. Butte,et al.  Autoimmune Disease Classification by Inverse Association with SNP Alleles , 2009, PLoS genetics.

[45]  K. Hemminki,et al.  Familial associations of rheumatoid arthritis with autoimmune diseases and related conditions. , 2009, Arthritis and rheumatism.

[46]  K. Liao,et al.  Specific association of type 1 diabetes mellitus with anti-cyclic citrullinated peptide-positive rheumatoid arthritis. , 2009, Arthritis and rheumatism.

[47]  S. Baranzini,et al.  Uncoupling the roles of HLA-DRB1 and HLA-DRB5 genes in multiple sclerosis , 2009, The Journal of Immunology.

[48]  S. Baranzini,et al.  Uncoupling the Roles of HLA-DRB1 and HLA-DRB5 Genes in Multiple Sclerosis1 , 2008, The Journal of Immunology.

[49]  S. Neuhausen,et al.  Co-occurrence of celiac disease and other autoimmune diseases in celiacs and their first-degree relatives. , 2008, Journal of autoimmunity.

[50]  L. Smeeth,et al.  Autoimmune Diseases Co-occurring Within Individuals and Within Families: A Systematic Review , 2006, Epidemiology.

[51]  Søren Højsgaard,et al.  The R Package geepack for Generalized Estimating Equations , 2005 .

[52]  F. Koning,et al.  The HLA-DQ2 gene dose effect in celiac disease is directly related to the magnitude and breadth of gluten-specific T cell responses , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[53]  B. Scott,et al.  The prevalence of coeliac disease in rheumatoid arthritis , 2002, European journal of gastroenterology & hepatology.

[54]  B. Buckingham,et al.  A randomized trial of methotrexate in newly diagnosed patients with type 1 diabetes mellitus. , 2000, Clinical immunology.

[55]  D. Paty,et al.  TNF neutralization in MS , 1999, Neurology.

[56]  D. Altman,et al.  Multiple significance tests: the Bonferroni method. , 1995, BMJ.

[57]  Y. Benjamini,et al.  Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .

[58]  J. Hillert,et al.  HLA class II-associated genetic susceptibility in multiple sclerosis: a critical evaluation. , 1991, Tissue antigens.

[59]  P. Gregersen,et al.  The shared epitope hypothesis. An approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. , 1987, Arthritis and rheumatism.

[60]  S. Zeger,et al.  Longitudinal data analysis using generalized linear models , 1986 .

[61]  C. Werning.  [Rheumatoid arthritis]. , 1983, Medizinische Monatsschrift fur Pharmazeuten.

[62]  P. Stastny.  Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. , 1978, The New England journal of medicine.